Form 8-K - Current report:
SEC Accession No. 0001437749-25-010494
Filing Date
2025-04-01
Accepted
2025-04-01 17:13:54
Documents
14
Period of Report
2025-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opk20250331_8k.htm   iXBRL 8-K 27633
  Complete submission text file 0001437749-25-010494.txt   165918

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA opk-20250328.xsd EX-101.SCH 3571
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20250328_def.xml EX-101.DEF 11421
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20250328_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20250328_pre.xml EX-101.PRE 11581
16 EXTRACTED XBRL INSTANCE DOCUMENT opk20250331_8k_htm.xml XML 2816
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 25800840
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)